10x Genomics, Inc.

LSE:0A88 Stock Report

Market Cap: US$1.7b

10x Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0A88 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Aug 24SellUS$66,710Justin McAnearIndividual2,961US$22.53
22 Aug 24SellUS$98,027Benjamin HindsonIndividual4,351US$22.53
22 Aug 24SellUS$152,053Serge SaxonovIndividual6,749US$22.53
22 May 24SellUS$118,529Serge SaxonovIndividual4,877US$24.30
22 May 24SellUS$71,355Justin McAnearIndividual2,936US$24.30
22 May 24SellUS$99,329Benjamin HindsonIndividual4,087US$24.30
04 Mar 24SellUS$205,021Serge SaxonovIndividual4,660US$44.00
22 Feb 24SellUS$86,432Justin McAnearIndividual1,865US$46.34
22 Feb 24SellUS$130,737Serge SaxonovIndividual2,821US$46.34
22 Feb 24SellUS$121,098Benjamin HindsonIndividual2,613US$46.34

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0A88?
Owner TypeNumber of SharesOwnership Percentage
State or Government45,4750.0376%
General Public2,357,3781.95%
Individual Insiders10,128,3398.37%
Institutions108,523,25689.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.

Top Shareholders

Top 25 shareholders own 80.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.1%
FMR LLC
18,238,630US$261.0m2%0.01%
9.06%
The Vanguard Group, Inc.
10,972,930US$157.0m7.69%no data
8.88%
ARK Investment Management LLC
10,750,345US$153.8m15.4%1.1%
5.63%
BlackRock, Inc.
6,815,370US$97.5m6.61%no data
5.26%
Nikko Asset Management Co., Ltd.
6,373,212US$91.2m3.75%0.03%
3.86%
T. Rowe Price Group, Inc.
4,677,678US$66.9m-7.13%0.01%
3.6%
Morgan Stanley Investment Management Inc.
4,353,634US$62.3m10.5%0.04%
3.32%
Serge Saxonov
4,024,114US$57.6m-0.03%no data
3.13%
VR Adviser, LLC
3,790,422US$54.2m0%2.43%
2.68%
Benjamin Hindson
3,238,266US$46.3m0.18%no data
2.3%
Citadel Advisors LLC
2,779,970US$39.8m731%0.04%
2.02%
John Stuelpnagel
2,441,337US$34.9m0%no data
1.81%
Brown Capital Management, LLC
2,195,319US$31.4m-11.6%0.39%
1.79%
UBS Asset Management AG
2,167,739US$31.0m4.32%no data
1.5%
Geode Capital Management, LLC
1,815,710US$26.0m2.41%no data
1.45%
State Street Global Advisors, Inc.
1,750,643US$25.1m7.13%no data
1.25%
Deerfield Management Company, L.P. Series C
1,508,943US$21.6m153%0.34%
1.21%
Point72 Asset Management, L.P.
1,466,227US$21.0m0%0.05%
1.19%
Credit Suisse Asset Management (Switzerland) Ltd.
1,438,122US$20.6m0%0.02%
1.17%
Voloridge Investment Management, LLC
1,414,804US$20.2m-1.75%0.07%
1.08%
Morgan Stanley, Investment Banking and Brokerage Investments
1,310,779US$18.8m27.6%no data
0.82%
Norges Bank Investment Management
991,051US$14.2m0%no data
0.79%
Soleus Capital Management, L.P.
951,000US$13.6m32.3%1.07%
0.76%
Millennium Management LLC
918,757US$13.1m-32.5%0.01%
0.67%
Eaton Vance Management
811,894US$11.6m0.79%no data